Objectives: To explore the patterns and determinants of reattendance among initial attendees at an organised breast cancer screening programme.
H igh quality mammography screening programmes can be effective in lowering breast cancer mortality in women aged over 50. 1, 2 Estimation of the bene t of mammography screening programmes is based on the premise that at least 70-75% of women in the target group will undergo repeated screening mammograms. [3] [4] [5] Maintenance of high levels of participation is thus crucial for the potential success of mass screening programmes. Regular attendance should ensure adherence to mammography screening recommendations, contribute to making the entire screening programme as cost-effective as possible, and indirectly re ect women's satisfaction with the intervention.
Across the variety of health service delivery systems, socio-demographic, structural and healthcare-mediated factors (mainly a recommendation from, or encouragement by, a doctor), as well as personal health behaviour appear to be the main quanti able determinants of attendance, although the same factor has sometimes been diversely, even oppositely, associated with attendance across studies. 2 The effect of cognitive (knowledge, behaviour, attitude, perception of personal risk) and emotional factors (anxiety, fear, pain, beliefs) on screening attendance has consistently been observed, 2, 6, 7 despite the dif culty in measuring psychosocial variables.
In contrast to the large body of research on initial attendance, comparatively little is known about factors that drive reattendance. Reluctance at initial attendance, 8 a negative previous experience with mammography examination (embarrassment, distress) or service screening staff, 9, 10 and a foreign language background 11, 12 appear to impair reattendance. While factors affecting reattendance and initial attendance probably differ, rst screens were not differentiated from subsequent screens in most studies. 2 Knowing which factors in uence women's decisions in re-attendance might suggest how participation could be increased.
This report explores the patterns and determinants of reattendance in the Swiss mammography screening pilot programme. 13 This experimental project, which demonstrated the feasibility and acceptability of an organised screening intervention within the Swiss liberal healthcare system, 14 has shown encouraging results of early screening effectiveness. 13 A companion analysis indicated that sociodemographic attributes which in uenced initial and repeated non-attendance differed in that population. 15 Two research questions were addressed: can a pattern of initial participants be identi ed that will predict reattendance in the next (second) screening round? And which determinants of reattendance are amenable to interventions aiming at increasing screening participation?
MATERIAL AND METHODS
According to national health surveys, self-reported mammography use is frequent in Switzerland, particularly in the canton of Vaud. 16 Prior to the pilot programme, in 1992-1993, about 20% of women aged 50-69 years reportedly performed annual mammography in this canton and 60% were ever-users. 13, 17 The Swiss breast cancer screening pilot programme was conducted between October 1993 and January 1999 in three districts of the French-speaking canton of Vaud. The recruitment and screening procedures and the criteria for administrative and medical eligibility have been detailed elsewhere. 13 Brie y, women aged 50-69 were invited every two years to attend a cost-free mammography test, to be undertaken in one of the two dedicated screening centres located within existing radiology units at regional, public hospitals. Non-respondents were sent up to two reminders. Reasons for nonparticipation were recorded. Some women anticipated their invitation (self-referrals) and initiated their screening appointment.
Municipality population registers provided sociodemographic records (name, date of birth, domicile, marital status, nationality and occupation). Information on screening attendance and screening outcome were obtained from the programme database. Data on women's health behaviour, level of education, medical history and referring physician were collected at each mammography session by interviews, using structured questionnaires, and conducted by two trained radiographers. Personal history of benign breast abnormality was validated to exclude cosmetic surgery, problems related to maternity, and other irrelevant mammary conditions with respect to breast cancer risk. Information on gender, board-certi ed specialty, year of achievement of medical degree and working place of referring physicians were validated and, when necessary, completed manually by one investigator (J-L Bulliard) using the Swiss of cial list of registered physicians. 18 A quality control of self-reporting was performed for repeated attendees, crosschecking the information recorded at the rst and second examinations. Concordance was overall excellent with less than 1% of erroneously discordant pairs. Data pertaining to the initial round were used prospectively to explore determinants of reattendance.
For the analyses, new variables were de ned. Socioeconomic status was assessed from the respective occupations of the woman and her partner. Distance between the domicile and the screening centre was derived from a geographical map. Levels of education were classi ed as low (<9 years: elementary primary/secondary school), middle (9-12 years: high school) and high (>12 years: at least some tertiary education) from the continuous variable 'years of education' and according to the Swiss education system. Interval level variables were indicator coded.
This study included 9086 women rst enrolled in the Vaud pilot programme between 1 October 1993 and 30 September 1995 and who were invited for the subsequent screening round ( Table 1 ). Investigation on reattendance was con ned to the 4162 rst-round participants. In absence of a universally accepted de nition for reattendance, no time limit was set for reattendance, so that a deferred participation was considered as reattendance (rather than classi ed as nonattendance). Determinants of reattendance were obtained by logistic regression analyses using the STATA software. 19 Univariate analysis of the effects of the independent variables on the odds of being a repeated attendee was rst performed. Variables with an overall p-value smaller than 0.25 were kept for multivariate analyses. 20 Records with missing values were discarded (5% of records). Variables were grouped a priori into four 'homogeneous' domains: (1) sociodemographic factors, (2) health preventive behaviour and history, (3) prior screening round and (4) attributes of the referring physician. Due to the large number of parameters and the correlation between variables belonging to the same domain, intermediate multivariate logistic regression analyses were performed separately for each of the four domains. For each of these, the main effects model was obtained by successive applications of a purposeful selection procedure according to the model building strategy recommended by Hosmer and Lemeshow. 21 Signi cant predictors of reattendance for each domain were retained and tted in a full multivariate logistic regression analysis. The statistical signi cance of relevant interactions was tested and the goodness-of-t of the nal models assessed.
RESULTS
Attendance was similar at the rst and second rounds, with 46% (4162/9086) and 45% (4108/9086) respectively ( Table  1 ). Some 55% attended either round. The reattendance rate (second round attendance among rst-round participants) was 80% (3318/4162). The proportion of rst-round nonparticipants who chose to attend the next screening round was similar to the proportion of rst-round participants who did not attend the second round (around 20%). Table 2 details the background characteristics of initial attendees. Most rst-round participants resided within 20 km from the screening site (92%), were Swiss (88%) and married (72%), of middle or high educational (88%) and socio-economic levels (77% of women with known socioeconomic status). Some 20% were reported to smoke, 34% had a prior mammography and 62% had a Pap smear within the last two years, 8% experienced a prior benign breast abnormality, 13% mentioned at least one relative with breast cancer, and 35% were prompted by a reminder letter before their initial participation. Some 98% speci ed a referring physician, who was predominantly a male doctor (73%), a gynaecologist (60%), and worked in the catchment area of the pilot trial (72%).
In univariate analysis, variables that had the greatest magnitude of effect on reattendance were nationality, distance to screening centre, socio-economic status, level of education, BMI, prior mammography and cervical screening, intensity of prior recruitment, outcome of previous screening round, as well as gender, specialty and time period of achievement of medical degree of the referring physician ( Table 2) . Women with a referring physician were four times more likely to reattend than those without a speci ed referring physician.
Results from multivariate analysis showed that non-Swiss (OR of reattendance = 0.63), those residing the farthest from the screening centre (OR 0.62) and ex-smokers (OR 0.67) were about 1.5 times less likely to reattend (Table 3) . Compared to women with no reported prior mammography experience, initial attendees whose previous screen occurred within the last ve years were signi cantly (about 1.7 times) more likely to be repeated attendees. The greater the efforts of initial recruitment, the lesser were the odds of reattendance. Having a false positive result in the rst round halved the chance of attending the next round (OR 0.46). Being followed by a female physician, a gynaecologist and a recently-licensed doctor signi cantly increased the odds of reattendance. Women whose referring physician worked in the pilot districts were more likely to reattend than women who had a physician based elsewhere (OR 0.74).
DISCUSSION
This study adds to our understanding of factors that in uence reattendance to an organised breast cancer screening programme in a country with a liberal healthcare system where there had been no previous population-based initiative of this kind, and where routine opportunistic screening is spreading. In the Swiss mammography screening pilot trial, a typical repeated attendee was identi ed as an urban Swiss resident, whose previous attendance resulted in a normal mammogram and was neither prompted by a reminder nor by her rst-round breast screening experience. This typical individual was followed by a female physician established in the programme catch-ment area and who practised gynaecology for no more than a decade. A high reattendance rate (80%) was achieved, even though initial screening attendance was modest (46%) and mammography could easily be obtained outside the organised programme. This study has several major strengths: the prospective study design, which minimised the possibility of recall bias; the effort of separating rst from subsequent round attendance when assessing determinants of participation, a distinction which may help disentangling or better clarifying the apparently contradictory results in the mammography attendance literature; and the availability of a large number of descriptive variables for all rst-round attendees, which has enabled to evaluate concurrently the in uence of various aspects of a screening programme on reattendance, including physician-speci c attributes.
Reattendance involves a self-selected group of women who have elicited to participate in organised screening and have overcome initial barriers to attendance. This group is probably more homogeneous than the whole target population and it is not surprising that factors in uencing initial and repeated attendance differ. 2 Two factors which already predicted a lower initial attendance, 15 a longer distance to the screening centre and a non-Swiss citizenship, were found to negatively in uence reattendance. Targeted sensitisation of this population group could thus be expected to improve both attendance and reattendance. Socio-economic status and notably the level of education tended to be lower among foreign than Swiss citizens (data not shown). First-round attendees of foreign background were also less likely to return to the next screening round in Australia and Canada. 11, 12 Given the proximity of the screening centres in this small Swiss area and the few women stating accessibility as a barrier to participation, 22 attitudes rather than accessibility appear likely to predominate in in uencing non-urban, foreign women in not reattending the programme. Urban women in higher socio-economic groups may also be more aware of the bene ts related to screening attendance beyond the rst visit than non-urban women in lower socio-economic classes. In this respect, distance may be an impediment considered anew each time by rural women.
Intensity of prior recruitment, which could re ect the woman's intention about screening, was the strongest determinant of reattendance. The inverse relationship between efforts of initial recruitment and reattendance con rmed earlier observations that reluctant initial attendees are the least likely to return for a second screen, 8 and that intention to attend is strongly predictive of future attendance. 8, 23, 24 This should by no means be taken to indicate that intensive efforts of recruitment are not worthy as attendance and, to a lesser degree, reattendance were substantially improved with one reminder letter (data not shown). Use of a single reminder has become a cost-effective practice adopted by on-going regional mammography screening programmes in Switzerland. 25 The higher reattendance rate among initial attendees who had a fairly recent (<5 years) mammography screening experience supports the assumption that prior mammography use indicates a preventive health orientation which favoured continued screening attendance. However, mammographic screening experience outside an organised programme has been reported to affect rescreening behaviour and reduce reattendance as these women might be more inclined to return to their prior individual screening habits. 8, 26 This was not observed in the Swiss pilot trial, as emphasised by a high reattendance rate.
Other health preventive behaviours positively in uenced reattendance. Having a cervical Pap smear test less than two years before the initial screen increased the chance of reattendance, although the effect of cervical screening disappeared when allowance was made for the referring physician's specialty. This was so as most women visiting a gynaecologist have regular smear screening. The observed signi cant lower odds ratio for reattendance among exsmokers compared to current smokers is dif cult to explain and was based on small numbers.
Women who received a false-positive result were twice less likely to return to the screening programme than truenegative cases. Whether a false-positive outcome lessens the next screening round attendance is a question leading to different interpretations across screening programmes. 9, 11, 23, [26] [27] [28] [29] The lower compliance in women with an abnormal screening result may re ect the effects of anxiety, discomfort and inconvenience resulting from the falsepositive result outweighing the perceived bene t of further screening. In our setting, investigations of positive mammograms are conducted by the referring physician who informs the patient about the nal diagnosis before notifying the screening programme. Many physicians have patients being screened both in and outside the screening programme and a fraction of false-positive cases may have elected, after counselling with or on recommendation of their doctor, to undergo individual screening or continued clinical follow-up.
This study corroborates the central role of referring physicians with regard to attendance in mammography screening programmes 2,30 and has identi ed physician's attributes in uencing repeated attendance in this Swiss population. Although physician-speci c attributes belong to the few factors amenable to intervention aiming at increasing attendance, 31 they have rarely been investigated concurrently with characteristics of attendees in organised mammography screening programmes.
In this region, most women are regularly followed by gynaecologists. Compared to other specialists, gynaecologists have a higher mammography prescription rate and a greater knowledge of breast cancer epidemiology and the bene ts of regular mammography screening. [32] [33] [34] Recently boardcerti ed doctors are likely to be more knowledgeable about mammography screening and the importance of community screening programmes than their older colleagues. The more favourable attitude of female physicians towards prevention in general and prescription of screening mammography in particular has been abundantly documented. 32, [35] [36] [37] Moreover, same-gender encounters can facilitate more effective communication and counselling in medical visits, especially for sensitive components of care such as female-speci c screening. 38 Female gender and younger age were both associated, though not to a statistically signi cant extent, with increased likelihood of prescribing mammography screening in a survey of 50-65 year-old practising physicians in Switzerland. 39 The motivation of local clinicians in setting up an experimental screening programme, along with the public and professional information surrounding the trial, are the main explanations for the higher reattendance among women whose regular physician practised in the pilot districts area. However, the present study does not enable us to separate the contribution of the physician recommendation and encouragement from the women's own decision to comply with mammography screening.
Complementary analyses showed that rst-round selfreferral was strongly associated with Swiss nationality, higher social class and educational level, and residence in the Morges district, where the trial was mainly developed. Self-initiated attendance was also positively related with having a recent (<12 months) cervical smear and no prior mammography screening use. Comparable pro le of selfreferred women were documented elsewhere, 40 except for the lower use of prior mammography screening, which has no obvious explanation. Self-referred women were also more likely than invited attendees to have a gynaecologist as a referring physician.
A personal invitation letter, a cost-free service, a prompt noti cation of results and low mean level of anxiety among participants 41 are probably of importance in explaining the high reattendance rate. A rst-round screening experience can also induce positive effects on cognitive barriers towards reattendance. 10 Unless a woman had a bad experience with screening, reattendance appears to be a matter of routine when cued, 42 and is thought to express satisfaction. 43 Although more than half of attendees were recruited among women who already performed breast screening before the set up of the pilot trial, over a quarter of attendees reported no prior use of mammography, most of them being repeated attendees. This suggests that this public health intervention has positively altered screening behaviour and reached a population segment which might have been hard to attain otherwise or particularly sensitive to the cost-free mammography screening test.
The absence of data on psychosocial characteristics and personal experience of women with the screening trial is a potential limitation in this study. Although some emotional factors have previously been examined in this population, 41 investigation on psychosocial, particularly cognitive, characteristics of type of attendees (self referrals, reluctant initial attendees, others) and non-attendees can shed light on mechanisms linked to screening (re)attendance. 44, 45 Efforts should continue to be directed mainly towards increasing initial attendance as this behavioural change tends to be long-lasting. In the Swiss as in other liberal healthcare systems, rm political willingness, public health and medical profession motivation are essential to achieve substantial increase in organised mammography screening attendance.
